mianserin has been researched along with Decerebrate Posturing in 2 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Roldán, JL | 1 |
| Torres, J | 1 |
| Marín, J | 1 |
| Leitch, IM | 1 |
| Rawlow, A | 1 |
| Rechtman, MP | 1 |
2 other studies available for mianserin and Decerebrate Posturing
| Article | Year |
|---|---|
Alpha-adrenoceptors involved on the cardiovascular response induced by mianserin in the pithed rat.
Topics: Animals; Blood Pressure; Decerebrate State; Electric Stimulation; Hemodynamics; Male; Mianserin; Nor | 1992 |
Pharmacological evaluation of two novel analogues of mianserin: 2-N-carboxamidinonormianserin (FCC5) and 2-N-carboxamidonormianserin (FCC13).
Topics: Animals; Blood Pressure; Bronchoconstriction; Catalepsy; Central Nervous System; Decerebrate State; | 1992 |